Anemias Completed Phase 2 Trials for Peginesatide (DB08894)

Also known as: Anemia / Anaemia / Anaemia, unspecified / Unspecified anaemia / Unspecified anemia / Anemia, unspecified / Anaemia NOS

IndicationStatusPhase
DBCOND0031070 (Anemias)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00314795Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseTreatment
NCT00434330Peginesatide for Maintenance Treatment of Anemia in Participants on HemodialysisTreatment
NCT00680043Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESATreatment
NCT00228436Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease PatientsTreatment
NCT00228449Peginesatide for Anemia in Chronic Hemodialysis PatientsTreatment
NCT00752609Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.Treatment
NCT00752791Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.Treatment